Coronary artery endothelial cells and microparticles increase expression of VCAM-1 in myocardial infarction

Thrombosis and Haemostasis

Volumn 113, Issue 3, 2015, Pages 605-616

  Radecke, Christopher E ^a   Warrick, Alexandra E ^b   Singh, Gagan D ^b   Rogers, Jason H ^b   Simon, Scott I ^a   Armstrong, Ehrin J ^c,d  

^a University of California Davis   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d VA Eastern Colorado Healthcare System   (United States)

Author keywords

Acute myocardial infarction; Adhesion molecules; Endothelial cells; Inflammation; Microparticles; VCAM 1

Indexed keywords

CD146 ANTIGEN; CREATINE KINASE; TROPONIN; VASCULAR CELL ADHESION MOLECULE 1; AUTACOID; BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; CELL ISOLATION; CELL VOLUME; CONTROLLED STUDY; CORONARY ARTERY; CORRELATION ANALYSIS; ENDOTHELIAL MICROPARTICLE; ENDOTHELIUM CELL; FEMALE; FLOW CYTOMETRY; HEART INFARCTION; HEART INFARCTION SIZE; HEMOLYSIS; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCORING SYSTEM; VASCULITIS; ATHEROSCLEROTIC PLAQUE; CELL CULTURE; CELL SEPARATION; CORONARY ARTERY DISEASE; CORONARY BLOOD VESSEL; MEMBRANE MICROPARTICLE; METABOLISM; MIDDLE AGED; MYOCARDIAL INFARCTION; PATHOLOGY; PROCEDURES; SEVERITY OF ILLNESS INDEX; TRANSLUMINAL CORONARY ANGIOPLASTY; UPREGULATION; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANGIOPLASTY, BALLOON, CORONARY; BIOMARKERS; CELL SEPARATION; CELL-DERIVED MICROPARTICLES; CELLS, CULTURED; CORONARY ARTERY DISEASE; CORONARY VESSELS; ENDOTHELIAL CELLS; FEMALE; FLOW CYTOMETRY; HUMANS; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLAQUE, ATHEROSCLEROTIC; SEVERITY OF ILLNESS INDEX; UP-REGULATION; VASCULAR CELL ADHESION MOLECULE-1;

EID: 84925307980     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH14-02-0151     Document Type: Article

References (49)

1. Heidenreich PA, Trogdon JG, Khavjou OA, et al. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation 2011; 123: 933–944.
2. Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke stat-istics--2012 update: a report from the American Heart Association. Circulation 2012; 125: e2-e220.
3. Cannon CP, Weintraub WS, Demopoulos LA, et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. New Engl J Med 2001; 344: 1879–1887.
4. Schwartz GG, Olsson AG, Ezekowitz MD, et al. Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering Study, Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. J Am Med Assoc 2001; 285: 1711–1718.
5. Curtis AM, Edelberg J, Jonas R, et al. Endothelial microparticles: sophisticated vesicles modulating vascular function. Vasc Med 2013; 18: 204–214.
6. Bonetti PO, Lerman LO, Lerman A. Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscl Thromb Vasc Biol 2003; 23: 168–175.
7. Davignon J, Ganz P. Role of endothelial dysfunction in atherosclerosis. Circulation 2004; 109, 327–32.
8. Ross R. Atherosclerosis--an inflammatory disease. New Engl J Med 1999; 340: 115–126.
9. Kinlay S, Ganz P. Role of endothelial dysfunction in coronary artery disease and implications for therapy. Am J Cardiol 1997; 80: 11I-16I.
10. Porto I, Biasucci LM, De Maria GL, et al. Intracoronary microparticles and microvascular obstruction in patients with ST elevation myocardial infarction undergoing primary percutaneous intervention. Eur Heart J 2012; 33: 2928–2938.
11. Zamani P, Schwartz GG, Olsson AG, et al. Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering Study, Inflammatory biomarkers, death, and recurrent nonfatal coronary events after an acute coronary syndrome in the MIRACL study. J Am Heart Assoc 2013; 2: e003103.
12. Malek AM, Alper SL, Izumo S. Hemodynamic shear stress and its role in atherosclerosis. J Am Med Assoc 1999; 282: 2035–2042.
13. DePaola N, Gimbrone MA, Davies PF, et al. Vascular endothelium responds to fluid shear stress gradients. Arterioscl Thromb 1992; 12: 1254–1257.
14. van der Heyde HC, Gramaglia I, Combes V. Flow cytometric analysis of micro-particles. Methods Mol Biol 2011; 699: 337–354.
15. Steppich B, Mattisek C, Sobczyk D, et al. Ott, Tissue factor pathway inhibitor on circulating microparticles in acute myocardial infarction. Thromb Haemost 2005; 93: 35–39.
16. Leroyer AS, Tedgui A, Boulanger CM. Role of microparticles in atherothrombo-sis. J Int Med 2008; 263: 528–537.
17. Diamant M, Tushuizen ME, Sturk A, et al. Cellular microparticles: new players in the field of vascular disease? Eur J Clin Invest 2004; 34: 392–401.
18. Feng L, Stern DM, Pile-Spellman J. Human endothelium: endovascular biopsy and molecular analysis. Radiology 1999; 212: 655–664.
19. Yu SY, Song YM, Li AM, et al. Isolation and characterisation of human coronary artery-derived endothelial cells in vivo from patients undergoing percutaneous coronary interventions. J Vasc Res 2009; 46: 487–494.
20. Gibson CM, Cannon CP, Murphy SA, et al. Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs. Circulation 2000; 101: 125–130.
21. Gibson CM, Cannon CP, Daley WL, et al. TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation 1996; 93: 879–888.
22. Ting HJ, Stice J P, Schaff U Y, et al. Triglyceride-rich lipoproteins prime aortic en-dothelium for an enhanced inflammatory response to tumor necrosis factor-alpha. Circ Res 2007; 100: 381–390.
23. Samsel L, Dagur PK, Raghavachari N, et al. Imaging flow cytometry for morphologic and phenotypic characterisation of rare circulating endothelial cells. Cytometry B 2013; 84: 379–389.
24. Mutin M, Canavy I, Blann A, et al. Direct evidence of endothelial injury in acute myocardial infarction and unstable angina by demonstration of circulating en-dothelial cells. Blood 1999; 93: 2951–2958.
25. Del Papa N, Colombo G, Fracchiolla N, et al. Circulating endothelial cells as a marker of ongoing vascular disease in systemic sclerosis. Arthritis Rheumatism 2004; 50: 1296–1304.
26. Mancuso P, Antoniotti P, Quarna J, et al. Validation of a standardized method for enumerating circulating endothelial cells and progenitors: flow cytometry and molecular and ultrastructural analyses. Clin Cancer Res 2009; 15: 267–273.
27. Mund JA, Estes ML, Yoder MC, et al. Flow cytometric identification and functional characterisation of immature and mature circulating endothelial cells. Ar-terioscl Thromb, Vasc Biol 2012; 32: 1045–1053.
28. Bardin N, Anfosso F, Masse JM, et al. Identification of CD146 as a component of the endothelial junction involved in the control of cell-cell cohesion. Blood 2001; 98: 3677–3684.
29. Estes ML, Mund JA, Ingram DA, et al. Identification of endothelial cells and progenitor cell subsets in human peripheral blood. In: Current protocols in cy-tometry, 2010.
30. Solovey A, Lin Y, Browne P, et al. Circulating activated endothelial cells in sickle cell anemia. N Engl J Med 1997; 337: 1584–1590.
31. Kas-Deelen AM, de Maar EF, Harmsen MC, et al. Uninfected and cytomegalic endothelial cells in blood during cytomegalovirus infection: effect of acute rejection. J Infectious Dis 2000; 181: 721–724.
32. Mutunga M, Fulton B, Bullock R, et al. Circulating endothelial cells in patients with septic shock. Am J Resp Crit Care Med 2001; 163: 195–200.
33. Kraan J, Strijbos MH, Sieuwerts AM, et al. A new approach for rapid and reliable enumeration of circulating endothelial cells in patients. J Thromb Hae-most 2012; 10: 931–939.
34. Makin AJ, Blann AD, Chung NA, et al. Assessment of endothelial damage in atherosclerotic vascular disease by quantification of circulating endothelial cells. Relationship with von Willebrand factor and tissue factor. Eur Heart J 2004; 25: 371–376.
35. Boos CJ, Lip G Y, Blann AD. Circulating endothelial cells in cardiovascular disease. J Am Coll Cardiol 2006; 48: 1538–1547.
36. Damani S, Bacconi A, Libiger O, et al. Characterisation of circulating endothe-lial cells in acute myocardial infarction. Science Transl Med 2012; 4: 126ra133.
37. Lee K W, Lip G Y, Tayebjee M, et al. Circulating endothelial cells, von Willebrand factor, interleukin-6, and prognosis in patients with acute coronary syndromes. Blood 2005; 105: 526–532.
38. Combes V, Simon AC, Grau GE, et al. In vitro generation of endothelial micro-particles and possible prothrombotic activity in patients with lupus anticoagulant. J Clin Invest 1999; 104: 93–102.
39. Bombeli T, Karsan A, Tait JF, et al. Apoptotic vascular endothelial cells become procoagulant. Blood 1997; 89: 2429–2442.
40. Iiyama K, Hajra L, Iiyama M, et al. Patterns of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 expression in rabbit and mouse atherosclerotic lesions and at sites predisposed to lesion formation. Circ Res 1999; 85: 199–207.
41. Li H, Cybulsky MI, Gimbrone MA et al. Inducible expression of vascular cell adhesion molecule-1 by vascular smooth muscle cells in vitro and within rabbit atheroma. Am J Path 1993; 143: 1551–1559.
42. Libby P, Li H. Vascular cell adhesion molecule-1 and smooth muscle cell activation during atherogenesis. J Clin Invest 1993; 92: 538–539.
43. Blankenberg S, Rupprecht HJ, Bickel C, et al. Circulating cell adhesion molecules and death in patients with coronary artery disease. Circulation 2001; 104: 1336–1342.
44. Shantsila E, Kamphuisen PW, Lip GY. Circulating microparticles in cardiovascular disease: implications for atherogenesis and atherothrombosis. J Thromb Haemost 2010; 8: 2358–2368.
45. Blann AD, Woywodt A, Bertolini F, et al. Circulating endothelial cells. Biom-arker of vascular disease. Thromb Haemost 2005; 93: 228–235.
46. Lehmann JM, Riethmuller G, Johnson J P. MUC18, a marker of tumor progression in human melanoma, shows sequence similarity to the neural cell adhesion molecules of the immunoglobulin superfamily. Proc Natl Acad Sci USA 1989; 86: 9891–9895.
47. Strijbos MH, Kraan J, den Bakker MA, et al. Cells meeting our immunopheno-typic criteria of endothelial cells are large platelets. Cytometry B 2007; 72: 86–93.
48. Morel O, Pereira B, Averous G, et al. Increased levels of procoagulant tissue factor-bearing microparticles within the occluded coronary artery of patients with ST-segment elevation myocardial infarction: role of endothelial damage and leukocyte activation. Atherosclerosis 2009; 204: 636–641.
49. Min PK, Kim JY, Chung KH, et al. Local increase in microparticles from the aspirate of culprit coronary arteries in patients with ST-segment elevation myo-cardial infarction. Atherosclerosis 2013; 227: 323–328.